GNRX News and Press, Market Vectors Generic Drugs ETF

The FDA has completed its long-anticipated guidance on interchangeability of biosimilars, allowing their substitution for reference biologics without prescribers' sign-off. More news on: AbbVie Inc., ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Tru...

Teva Pharmaceutical Industries (NYSE: TEVA ) slumps  8%  premarket on light volume as investors react to its role in alleged price fixing by generic drug firms. Last night, the investigative journalism show 60 Minutes aired a piece on the issue that named the company as one of th...

In lockstep with the U.S., Canadian officials are poised to implement a new initiative aimed at corralling high prescription drug costs, despite an offer by drug makers to pay C$8.6B (US$6.6B) over 10 years, freeze prices or reduce the cost of treating rare diseases. More news on: ProSha...

Following through on its commitment to promote lower drug costs, the Trump administration announces that pharmaceutical and biotech companies will be required to disclose prices in television commercials for medications covered by Medicare that cost more than $35 for a month's supply (mean...

Additional proposals in President Trump's 2020 budget aimed at drug prices: More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla World Healthcare Fund, Healthcare stocks news, News on ETFs, Read more ...

President Trump's 2020 budget includes variety of proposed initiatives to address drug prices. Highlights: More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla World Healthcare Fund, Healthcare stocks news, News on ETFs, Read m...

President Trump's 2020 budget of $4.7T includes ~$1.3T in health spending , an increase of ~$18.3B this year. Mandatory funding is $1.2T while discretionary spending is $87.1B. Highlights: More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Tru...

In a statement , FDA Commissioner Scott Gottlieb, M.D. says the agency has submitted its request for $6.1B in funding for fiscal 2020, an increase of $643M from this fiscal year. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla ...

The Trump administration is reaching out to the medical industry for feedback on requiring hospitals, doctors and other healthcare providers to publicly disclose the heretofore confidential prices they charge insurers for services, a move than would upend the industry (at least for awhile)...

VanEck, one of the largest providers of exchange traded funds (“ETFs”) in the U.S. and worldwide with approximately $47.8 billion in assets under management as of January 31, 2019, announced today that it plans to close and liquidate three VanEck Vectors ETFs. On March 4, 2...